No weight loss after 3 weeks on Mounjaro — what's actually happening

What the SURMOUNT-1 trial tells us about early weeks

The SURMOUNT-1 trial followed 2,539 adults with obesity over 72 weeks and recorded average body-weight reductions of around 20–21% at the 15mg maintenance dose. But that figure represents the end of a long, graduated journey. Participants spent the first eight weeks at the two lowest doses (2.5mg and then 5mg) precisely because tirzepatide's mechanism needs time and a therapeutic dose to express itself fully.

At 2.5mg, the medicine's dual GIP and GLP-1 receptor activity is present but its appetite-suppressing and gastric-emptying effects are deliberately dampened to reduce early nausea. The clinical programme was never designed to produce rapid early weight loss; it was designed to produce sustained, substantial weight loss with tolerable side effects. Three weeks in, at the starter dose, you are still in the system-adjustment window.

This is not a reason to feel discouraged. It is a reason to read the early weeks differently. The full tirzepatide evidence picture makes more sense once you understand that the dose you receive on day one is not the dose that drives the results seen in trials.

Four things that can keep the scales flat in the first three weeks

The absence of visible scale movement early on usually has a physiological explanation rather than a treatment failure. First, water retention: when your eating pattern begins to shift (even slightly) glycogen stores in the liver and muscle release bound water, but the body can simultaneously retain fluid in other compartments. The two effects can cancel each other out for a week or two.

Second, lean mass preservation: tirzepatide tends to preserve muscle tissue more than very-low-calorie crash dieting. If you have started any resistance exercise alongside treatment, you may be building a small amount of muscle mass at the same time as losing fat, again, the scales do not distinguish. Third, individual variation in gastric-emptying response is real; some people feel the appetite effect within days, others take several weeks to notice a meaningful shift in hunger. Fourth, food choices matter: even with reduced appetite, calorie composition, sodium intake and hydration all influence what a scale reads on a given morning.

None of this means the medicine is not working. It means the early weeks are not the most informative window for judging treatment response. Our guide to what Mounjaro weight loss typically looks like across the first four weeks covers the timeline in more detail.

When no weight loss after three weeks deserves a closer look

Context matters. If you have already titrated beyond 2.5mg by week three (which would only happen under clinical guidance) the picture is different from someone still on the starter pen. If you have reached 5mg or higher and still see no change at three weeks, it is worth logging what has and has not changed in your appetite, hunger between meals and portion sizes. A medicine that is working often shows up there before the scales move.

Persistent absence of any change alongside no reduction in appetite at higher doses is worth raising with whoever is overseeing your treatment. At nume, aftercare is available seven days a week precisely for moments like this, a question to our prescribers is the right first step rather than adjusting anything independently. For a broader look at what happens if things are still flat further down the line, the page on Mounjaro with no weight loss at six weeks works through the considerations prescribers weigh at that point.

The NHS tirzepatide medicines page is also a reliable place to read what is considered a normal pattern of response. Mounjaro's cost context (and what private treatment actually includes) is covered on our Mounjaro cost page if that question is on your mind too.

What happens next, and why patience is a clinical instruction, not a platitude

Tirzepatide titration follows a structured schedule because the body needs time to adapt at each dose step. Jumping ahead or stopping early both carry clinical risks, the prescriber who set your starting dose did so for reasons grounded in the medicine's safety profile. The instruction to stay at 2.5mg for the first four weeks before any increase is part of the licensed plan, not an arbitrary pause.

Most people who see modest early results go on to significant weight loss once they reach their optimal maintenance dose and maintain consistent habits alongside it. If you are three weeks in and finding it harder than expected, that conversation belongs with your prescriber, not a forum, not a dose change decided alone. Our overview of the three-week mark on Mounjaro covers the broader picture of what this stage typically looks and feels like.

Starting a free consultation with our team means a real prescriber reads your answers the same day. If Mounjaro is clinically right for you, you can read about how we supply it through our Mounjaro MediExpress service, which sets out how treatment is dispatched the same day and arrives the next working day via DPD, tracked to your door, in plain packaging. That process is described in full on our weight-loss treatments page.